Objective: The family caregiver's role (FCG) is largely uninvestigated among head and neck cancer patients. 1) To better detail the role of FCG. 2) To evaluate quality of life (QoL) and psychological distress of FCGs and patients. 3) To investigate relationships between FCG's well being and patient's QoL and emotional pattern.
Results:
Patients: state and trait anxiety are 46.7% (STAI-Y1 mean value 40.2 ± 10.2; cutoff 40) and 36.7% (STAI-Y2 mean value 36.7 ± 8.2; cutoff 40) respectively; self-reported and clinicianrated depression are 31.6% (BDI mean value 8.2 ± 5.3; cutoff 9) and 48.3% (MDRS mean value 7.9 ± 5.9; cutoff 6), respectively. CGs: state and trait anxiety are 50% (STAI-Y1 mean value 42.5 ± 9.9; cutoff 40) and 41.7% (STAI-Y2 mean value 39.1 ± 8.7; cutoff 40), respectively; self-reported and clinician-rated depression are 28.3% (BDI mean value 7.3 ± 4.7; cutoff 9) and 41.7% (MDRS mean value 7.6 ± 5.8; cutoff 6), respectively. Positive association among emotional scales of patients and caregivers was observed. Patients' psychological aspects are negatively associated with CGs' QoL and vice versa.
Conclusion: Anxiety and depression are often present in FCGs and cured HNC patients. Long-term patients' QoL is the result of a frail balance between FCG and patient emotional and psychological distress. A psychological support for FCG could improve patient well-being.
Head and Neck Surgery the Role of Fine-Needle aspiration in Parotid Pleomorphic adenoma
Christopher E. Fundakowski, MD (presenter); Jonathan Castano; Marianne Abouyared; Andrew Rivera; Rosemary Ojo, MD; Zoukaa Sargi, MD Objective: Fine-needle aspiration (FNA) biopsy is often used as a well-accepted and both sensitive and specific diagnostic adjunct in the workup of parotid masses. In the case of pleomorphic adenoma, the most common benign tumor of the parotid gland, we examine cytopathologic reports to assess the performance of FNA for this particular histologic diagnosis.
Method: A total of 317 patients who underwent parotidectomy over the past 5 years and met eligibility criteria of 1) primary parotid tumor, 2) age greater than 18 years, and 3) availability of pathology (FNA, intraoperative frozen section, final pathology) were reviewed. Clinical history and demographics, physical exam findings, and intraoperative findings were noted.
Results: Pleomorphic adenoma was noted on final pathology in 136 patients (42.9%). Interestingly 24 (17.6%) of these patients had initially undergone FNA and been given a incorrect diagnosis, despite the FNA being "diagnostic." One patient received false positive diagnosis of malignancy by FNA. Of the 24 patients with incorrect diagnosis on FNA, 15 (62.5%) received the correct diagnosis of pleomorphic adenoma with intraoperative frozen section, though one patient received a false positive for malignancy and underwent surgical upstage unnecessarily. For pleomorphic adenoma, it appears that diagnostic sensitivity increases from 82% for FNA to 92% with frozen section.
Conclusion:
While FNA is commonly used as preoperative diagnostic adjunct for parotid masses, one must exercise caution, even in the context of a diagnostic sample, as nearly 18% of pleomorphic adenomas were not identified. Fortunately, misdiagnosis was benign 95% of time, and subsequently had no surgical implications.
Head and Neck Surgery the Role of G9a in tumorigenesis in Head and Neck Cancer
Ching-Ting Tan, MD, PhD (presenter); Jenq-Yuh Ko; Hung-Huey Tsai Objective: Head and neck squamous cell carcinoma (HNSCC) represents a major worldwide health problem with patients, exhibiting a 5-year average survival rate lower than 50%. G9a is a histone methyltransferase (HMTase) for histone H3 lysine 9 dimethylation (H3K9me2), and it was reported that G9amediated H3K9me2 aberrantly repressed tumor suppressor genes in many cancers. However, the mechanistic understanding of the role of G9a in HNSCC progression remains largely unknown.
Method: IHC of patients' tissues were performed. RT-PCR, western blot, cell viability assay, and anchorage-independent growth analysis of HNSCC cells were performed. Age-matched NOD-SCID mice were used to establish the mouse model for tumorigenesis. Microarray analysis was scanned with the AffymetriGeneChip scanner to evaluate the signal pathway regulated by G9a.
Results:
The results revealed that mRNA expression level of G9a was higher in tumors compared with normal parts. G9a was over-expressed in cancerous specimens compared with mucosa. Inhibited G9a expression by shRNA or treated G9a enzymatic activity inhibitor BIX-01294 in HNSCC cells, the results showed that both can significantly inhibit HNSCC cell growth and anchorage-independent growth. The in vivo
